Sangamo's Lanphier to retire

Sangamo BioSciences Inc. (NASDAQ:SGMO) said Edward Lanphier is retiring as president and CEO, a position he has held since Sangamo was founded in 1995.

Sangamo named Alexander Macrae as Lanphier's replacement, effective immediately. He was global medical officer at Takeda Pharmaceutical Co. Ltd. (Tokyo:4502). ...